NPORT-EX 2 edgar.htm
Schedule of Investments
July 31, 2023
(Unaudited)
  Shares Value
Common Stocks & Other Equity Interests–94.33%
Belgium–0.57%
Biocartis Group N.V.(a)(b)(c) 6,982,992     $2,625,801
Materialise N.V., ADR(a)(c) 2,900,000    23,142,000
      25,767,801
Denmark–2.79%
Atlantic Sapphire ASA(c) 6,169,427     3,751,778
Bavarian Nordic A/S(c) 2,560,000    54,945,686
Genmab A/S(c) 100,000    41,240,519
Novozymes A/S, Class B 500,000    25,045,690
      124,983,673
France–1.03%
Mersen S.A. 983,743    46,299,695
Vantiva S.A.(c) 570,324       120,247
      46,419,942
Germany–5.73%
AIXTRON SE 3,660,000   145,352,685
Basler AG(a) 1,584,283    25,991,288
Carl Zeiss Meditec AG, BR 200,000    23,163,044
Manz AG(a)(c) 466,570     8,667,013
PVA TePla AG(a)(c) 2,282,096    53,739,228
      256,913,258
Ireland–1.21%
Ads-Tec Energy PLC(c) 2,319,856    14,383,107
Flutter Entertainment PLC(c) 200,000    39,843,736
      54,226,843
Italy–1.69%
Brunello Cucinelli S.p.A. 894,764    75,728,108
Japan–14.87%
Comture Corp.(a) 2,500,000    35,568,094
CyberAgent, Inc. 5,200,000    32,808,964
Disco Corp. 524,000    98,426,612
Jeol Ltd. 2,160,000    74,078,296
M3, Inc. 2,560,000    59,433,148
Mercari, Inc.(c) 1,000,000    25,290,700
Nidec Corp. 600,000    35,617,786
Nikon Corp. 2,000,000    26,419,550
Optex Group Co. Ltd.(a) 1,387,800    18,212,969
PeptiDream, Inc.(c) 4,000,000    50,931,085
Rheon Automatic Machinery Co. Ltd. 330,700     3,380,341
SHIFT, Inc.(c) 550,000   130,280,590
Yaskawa Electric Corp. 1,760,000    76,525,546
      666,973,681
Norway–3.21%
Mowi ASA 4,000,000    70,329,030
Nordic Semiconductor ASA(c) 4,999,999    73,639,575
      143,968,605
Sweden–6.25%
AddTech AB, Class B 2,500,000    46,410,878
Beijer Ref AB 3,350,000    45,390,607
  Shares Value
Sweden–(continued)
Boozt AB(a)(b)(c) 3,750,000    $44,704,977
Indutrade AB 2,691,106    56,422,757
Midsona AB, Class B(c) 1,708,521     1,208,752
RaySearch Laboratories AB(a)(c) 4,000,000    27,100,015
Surgical Science Sweden AB(c) 1,000,000    23,310,306
Tobii AB(c) 3,000,000     5,518,610
Xvivo Perfusion AB(c) 1,000,000    30,247,663
      280,314,565
Switzerland–0.10%
GeNeuro S.A.(a)(c) 2,457,241     4,570,332
United Kingdom–15.91%
ASOS PLC(c) 700,000     3,773,699
Aston Martin Lagonda Global Holdings PLC(b)(c) 68,894,357   350,056,817
boohoo Group PLC(c) 30,000,000    14,983,888
FD Technologies PLC(c) 1,200,000    27,560,666
Fevertree Drinks PLC 2,000,000    34,423,983
Frontier Developments PLC(a)(c) 2,243,918    16,895,027
Future PLC 1,000,000    10,755,924
Gooch & Housego PLC(a) 1,479,236    10,901,846
IP Group PLC 14,546,226    11,155,222
IQE PLC(a)(c) 142,917,198    36,274,998
M&C Saatchi PLC 5,230,352     8,920,162
Oxford Nanopore Technologies PLC(c) 31,476,911   106,692,053
Spirax-Sarco Engineering PLC 200,000    28,572,257
WANdisco PLC(a)(c) 10,594,145    16,315,188
Xaar PLC(a)(c) 6,000,000    14,628,774
Zoo Digital Group PLC(a)(c) 6,320,647     5,758,619
Zotefoams PLC(a) 3,200,000    16,337,083
      714,006,206
United States–40.97%
3D Systems Corp.(c) 5,000,000    43,550,000
Advanced Micro Devices, Inc.(c) 3,000,000   343,200,000
Align Technology, Inc.(c) 100,000    37,789,000
Arrowhead Pharmaceuticals, Inc.(c) 2,000,000    69,040,000
Cognex Corp. 1,200,000    65,544,000
Coherent Corp.(c) 1,000,000    47,360,000
Exact Sciences Corp.(c) 1,800,000   175,572,000
Globant S.A.(c) 200,000    34,946,000
Impinj, Inc.(c) 400,000    26,648,000
IPG Photonics Corp.(c) 600,000    78,870,000
Ivanhoe Electric, Inc.(c) 2,000,000    32,520,000
Littelfuse, Inc. 200,000    60,920,000
Manhattan Associates, Inc.(c) 600,000   114,372,000
Nevro Corp.(c) 1,000,000    24,990,000
ON Semiconductor Corp.(c) 500,000    53,875,000
PDF Solutions, Inc.(a)(c) 3,000,000   137,970,000
PTC, Inc.(c) 1,000,000   145,810,000
QUALCOMM, Inc. 500,000    66,085,000
Shake Shack, Inc., Class A(c) 1,000,000    77,660,000
Veeco Instruments, Inc.(a)(c) 3,000,000    84,480,000
Vicor Corp.(c) 500,000    46,135,000
Wolfspeed, Inc.(c) 1,000,000    65,900,000
 
See accompanying notes which are an integral part of this schedule.
Invesco Global Opportunities Fund
  Shares Value
United States–(continued)
Xeris Biopharma Holdings, Inc.(c) 2,000,000     $5,220,000
      1,838,456,000
Total Common Stocks & Other Equity Interests (Cost $3,159,232,056) 4,232,329,014
Money Market Funds–5.41%
Invesco Government & Agency Portfolio, Institutional Class, 5.18%(a)(d) 84,923,999    84,923,999
Invesco Liquid Assets Portfolio, Institutional Class, 5.28%(a)(d) 60,644,846    60,650,910
  Shares Value
Money Market Funds–(continued)
Invesco Treasury Portfolio, Institutional Class, 5.18%(a)(d) 97,055,998    $97,055,998
Total Money Market Funds (Cost $242,634,910) 242,630,907
TOTAL INVESTMENTS IN SECURITIES—99.74% (Cost $3,401,866,966) 4,474,959,921
OTHER ASSETS LESS LIABILITIES–0.26% 11,773,428
NET ASSETS–100.00% $4,486,733,349
Investment Abbreviations:
ADR – American Depositary Receipt
BR – Bearer Shares
Notes to Schedule of Investments:
(a) Affiliated issuer. The issuer is affiliated by having an investment adviser that is under common control of Invesco Ltd. and/or is an "affiliated person" under the Investment Company Act of 1940, as amended (the “1940 Act”), which defines “affiliated person” to include an issuer of which a fund holds 5% or more of the outstanding voting securities. For the Investments in Other Affiliates below, the Fund has not owned enough of the outstanding voting securities of the issuer to have control (as defined in the 1940 Act) of that issuer. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the nine months ended July 31, 2023.
    
  Value
October 31, 2022 		Purchases
at Cost 		Proceeds
from Sales 		Change in
Unrealized
Appreciation
(Depreciation) 		Realized
Gain
(Loss) 		Value
July 31, 2023 		Dividend Income
Investments in Affiliated Money Market Funds:              
Invesco Government & Agency Portfolio, Institutional Class $81,100,213 $244,802,304 $(240,978,518) $- $- $84,923,999 $1,915,937
Invesco Liquid Assets Portfolio, Institutional Class 51,103,361 174,858,789 (165,304,124) (15,575) 8,459 60,650,910 1,377,568
Invesco Treasury Portfolio, Institutional Class 92,685,957 279,774,062 (275,404,021) - - 97,055,998 2,185,434
Investments in Other Affiliates:              
Aumann Ag 11,861,710 - (14,054,034) 47,558,191 (45,365,867) - -
Basler AG 48,931,519 - (4,487,395) (16,750,919) (1,701,917) 25,991,288 224,145
Biocartis Group N.V. 7,106,383 7,330,294 (998,113) 22,169,205 (32,981,968) 2,625,801 -
Boozt AB 27,374,742 - - 17,330,235 - 44,704,977 -
Comture Corp. 48,775,634 - (7,177,096) (3,158,807) (2,871,637) 35,568,094 645,550
Frontier Developments PLC 45,619,685 - (5,322,021) (11,133,044) (12,269,593) 16,895,027 -
GeNeuro S.A. 4,128,332 - - 442,000 - 4,570,332 -
Gooch & Housego PLC 11,009,275 - (4,031,912) 12,288,811 (8,364,328) 10,901,846 310,126
IQE PLC 67,203,506 2,879,532 (2,267,235) (15,441,781) (16,099,024) 36,274,998 -
Manz AG 13,121,717 - (705,860) (3,009,461) (739,383) 8,667,013 -
Materialise N.V., ADR* 30,711,000 - - (7,569,000) - 23,142,000 -
Nektar Therapeutics 134,495,200 - (20,931,278) 508,216,066 (621,779,988) - -
Optex Group Co. Ltd.* 27,540,836 - (8,405,619) 8,522,052 (9,444,300) 18,212,969 458,495
PDF Solutions, Inc. 70,740,000 - - 67,230,000 - 137,970,000 -
PVA TePla AG 48,529,344 - (12,554,843) 21,838,255 (4,073,528) 53,739,228 -
RaySearch Laboratories AB 20,788,083 - - 6,311,932 - 27,100,015 -
Rovio Entertainment OYJ 26,803,800 - (41,712,223) 13,773,790 1,134,633 - -
Veeco Instruments, Inc. 54,690,000 - - 29,790,000 - 84,480,000 -
WANdisco PLC 25,109,582 3,556,476 - (12,350,870) - 16,315,188 -
Xaar PLC 11,672,694 - - 2,956,080 - 14,628,774 -
Zoo Digital Group PLC 13,245,534 - (1,044,404) (6,512,916) 70,405 5,758,619 -
Zotefoams PLC 13,509,174 - (3,590,255) 7,460,904 (1,042,740) 16,337,083 232,756
Total $987,857,281 $713,201,457 $(808,968,951) $689,945,148 $(755,520,776) $826,514,159 $7,350,011
    
* At July 31, 2023, this security was was no longer an affiliate of the Fund.
    
See accompanying notes which are an integral part of this schedule.
Invesco Global Opportunities Fund
(b) Security purchased or received in a transaction exempt from registration under the Securities Act of 1933, as amended (the “1933 Act”). The security may be resold pursuant to an exemption from registration under the 1933 Act, typically to qualified institutional buyers. The aggregate value of these securities at July 31, 2023 was $397,387,595, which represented 8.86% of the Fund’s Net Assets.
(c) Non-income producing security.
(d) The rate shown is the 7-day SEC standardized yield as of July 31, 2023.
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Invesco Global Opportunities Fund
Notes to Quarterly Schedule of Portfolio Holdings
July 31, 2023
(Unaudited)
NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment’s assigned level:
Level 1 – Prices are determined using quoted prices in an active market for identical assets.
Level 2 – Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.
Level 3 – Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.  Unobservable inputs reflect Invesco Advisers, Inc.’s assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.
The following is a summary of the tiered valuation input levels, as of July 31, 2023. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.
  Level 1 Level 2 Level 3 Total
Investments in Securities        
Belgium $23,142,000 $2,625,801 $— $25,767,801
Denmark — 124,983,673 — 124,983,673
France — 46,419,942 — 46,419,942
Germany — 256,913,258 — 256,913,258
Ireland 14,383,107 39,843,736 — 54,226,843
Italy — 75,728,108 — 75,728,108
Japan — 666,973,681 — 666,973,681
Norway — 143,968,605 — 143,968,605
Sweden — 280,314,565 — 280,314,565
Switzerland — 4,570,332 — 4,570,332
United Kingdom 16,315,188 697,691,018 — 714,006,206
United States 1,838,456,000 — — 1,838,456,000
Money Market Funds 242,630,907 — — 242,630,907
Total Investments $2,134,927,202 $2,340,032,719 $— $4,474,959,921
Invesco Global Opportunities Fund